Name | Lesabelimab |
---|
Description | Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor[1][2]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |